InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,314.97
(
0.13%
)
US TECH 100
18,182.80
(
-0.07%
)
Dow Jones
39,871.36
(
0.16%
)
Brent Oil
83.08
(
-0.54%
)
Bitcoin
70,348.80
(
-1.54%
)
Post# of 424405
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

sharinky

Send PM Follow Ignore
Followers 7
Posts 1173
Boards Moderated 0
Alias Born 11/13/2018

sharinky

Re: None

Saturday, 11/23/2019 12:18:12 PM

Saturday, November 23, 2019 12:18:12 PM

Post# of 424405
NOV 19 • HLS Therapeutics Inc (HLS). Canaccord Genuity initiates coverage with buy rating and a target price of C$22.50, saying the company’s drug Vascepa is expected to improve net sales and EBITDA.

Current price C$17.92

Not sure if this got posted this week. The more exposure HLS gets the better.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News
InvestorsHub NewsWire

North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM

Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM

Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM

VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM

ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM

Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM

Start posting your company's news
Only $200 per official company press release!